BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 17570538)

  • 1. Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine.
    Zhang M; Ballard ME; Unger LV; Haupt A; Gross G; Decker MW; Drescher KU; Rueter LE
    Behav Brain Res; 2007 Aug; 182(1):1-11. PubMed ID: 17570538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats.
    Barr AM; Powell SB; Markou A; Geyer MA
    Neuropharmacology; 2006 Sep; 51(3):457-65. PubMed ID: 16762376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of LU-111995 in three models of disrupted prepulse inhibition in rats.
    Geyer MA; Swerdlow NR; Lehmann-Masten V; Teschendorf HJ; Traut M; Gross G
    J Pharmacol Exp Ther; 1999 Aug; 290(2):716-24. PubMed ID: 10411583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.
    Ballmaier M; Zoli M; Mazzoncini R; Gennarelli M; Spano F
    Psychopharmacology (Berl); 2001 Dec; 159(1):105-10. PubMed ID: 11797077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist.
    Bakshi VP; Geyer MA
    J Pharmacol Exp Ther; 1997 Nov; 283(2):666-74. PubMed ID: 9353384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agmatine disrupts prepulse inhibition of acoustic startle reflex in rats.
    Uzbay T; Kayir H; Goktalay G; Yildirim M
    J Psychopharmacol; 2010 Jun; 24(6):923-9. PubMed ID: 19282421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat.
    Swerdlow NR; Keith VA; Braff DL; Geyer MA
    J Pharmacol Exp Ther; 1991 Feb; 256(2):530-6. PubMed ID: 1825226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
    Auclair AL; Kleven MS; Besnard J; Depoortère R; Newman-Tancredi A
    Neuropsychopharmacology; 2006 Sep; 31(9):1900-9. PubMed ID: 16421514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCH 23390 in the prefrontal cortex enhances the effect of apomorphine on prepulse inhibition of rats.
    de Jong IE; van den Buuse M
    Neuropharmacology; 2006 Sep; 51(3):438-46. PubMed ID: 16740279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ameliorating effects of tropisetron on dopaminergic disruption of prepulse inhibition via the alpha(7) nicotinic acetylcholine receptor in Wistar rats.
    Kohnomi S; Suemaru K; Goda M; Choshi T; Hibino S; Kawasaki H; Araki H
    Brain Res; 2010 Sep; 1353():152-8. PubMed ID: 20673759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Typical" but not "atypical" antipsychotic effects on startle gating deficits in prepubertal rats.
    Martinez ZA; Platten A; Pollack E; Shoemaker J; Ro H; Pitcher L; Geyer MA; Swerdlow NR
    Psychopharmacology (Berl); 2002 Apr; 161(1):38-46. PubMed ID: 11967629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI.
    Shilling PD; Feifel D
    Psychopharmacology (Berl); 2002 Nov; 164(3):285-93. PubMed ID: 12424552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat.
    Stanhope KJ; Mirza NR; Bickerdike MJ; Bright JL; Harrington NR; Hesselink MB; Kennett GA; Lightowler S; Sheardown MJ; Syed R; Upton RL; Wadsworth G; Weiss SM; Wyatt A
    J Pharmacol Exp Ther; 2001 Nov; 299(2):782-92. PubMed ID: 11602695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats.
    Jones CK; Eberle EL; Shaw DB; McKinzie DL; Shannon HE
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1055-63. PubMed ID: 15574685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on prepulse inhibition of the acoustic startle reflex in rat.
    Satake S; Yamada K; Melo LL; Barbosa Silva R
    Neurosci Lett; 2012 Feb; 509(1):60-3. PubMed ID: 22230886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine enhances disruption of prepulse inhibition after sub-chronic dizocilpine- or phencyclidine-treatment in Wistar rats.
    Schwabe K; Brosda J; Wegener N; Koch M
    Pharmacol Biochem Behav; 2005 Feb; 80(2):213-9. PubMed ID: 15680174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of "enriched environment" during development on adult rat behavior and response to the dopamine receptor agonist apomorphine.
    Hoffmann LC; Schütte SR; Koch M; Schwabe K
    Neuroscience; 2009 Feb; 158(4):1589-98. PubMed ID: 19110038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurotensin agonist NT69L improves sensorimotor gating deficits in rats induced by a glutamatergic antagonist, but not by dopaminergic agonists.
    Secchi RL; Sung E; Hedley LR; Button D; Schreiber R
    Behav Brain Res; 2009 Sep; 202(2):192-7. PubMed ID: 19463701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of antipsychotic drugs on serotonin-1A receptor-mediated disruption of prepulse inhibition.
    van den Buuse M; Gogos A
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1224-36. PubMed ID: 17194799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.